Merck on Wednesday announced it had entered into an agreement with Singapore to provide molnupiravir, an investigational antiviral drug to treat Covid-19, once it is authorised or approved.Molnupiravir is designed to introduce errors into the genetic code of the virus and would be the first oral antiviral medication for Covid-19. Merck is seeking approval by the US Food and Drug Administration for the pill.Singapore’s health ministry did not immediately respond to a request for confirmation of…
We understand Legal Issues in Asia